Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma.
Saved in:
| Title: | Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma. |
|---|---|
| Authors: | Gamboa-Cedeño AM; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina., Díaz M; Research Area, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina., Cristaldo N; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., Otero V; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., Schutz N; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., Fantl D; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., Cugliari S; Hematology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina., Zerga M; Hematology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina., Rojas-Bilbao E; Pathology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina., Jauk F; Sequencing Laboratory, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., García Rivello H; Pathology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina., Nuñez M; School of Pharmacy and Biochemistry (FFyB), Universidad de Buenos Aires, Buenos Aires, Argentina., Ranuncolo SM; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina; Research Area, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina. Electronic address: smranuncolo@gmail.com. |
| Source: | Life sciences [Life Sci] 2021 Mar 01; Vol. 268, pp. 118979. Date of Electronic Publication: 2021 Jan 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33421528 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gamboa-Cedeño+AM%22">Gamboa-Cedeño AM</searchLink>; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Díaz+M%22">Díaz M</searchLink>; Research Area, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina.<br /><searchLink fieldCode="AU" term="%22Cristaldo+N%22">Cristaldo N</searchLink>; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Otero+V%22">Otero V</searchLink>; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Schutz+N%22">Schutz N</searchLink>; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Fantl+D%22">Fantl D</searchLink>; Hematology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Cugliari+S%22">Cugliari S</searchLink>; Hematology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Zerga+M%22">Zerga M</searchLink>; Hematology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Rojas-Bilbao+E%22">Rojas-Bilbao E</searchLink>; Pathology, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Jauk+F%22">Jauk F</searchLink>; Sequencing Laboratory, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22García+Rivello+H%22">García Rivello H</searchLink>; Pathology, Italian Hospital of Buenos Aires (HIBA), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Nuñez+M%22">Nuñez M</searchLink>; School of Pharmacy and Biochemistry (FFyB), Universidad de Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Ranuncolo+SM%22">Ranuncolo SM</searchLink>; Traslational Medicine and Biomedical Engineering Institute (IMTIB), Buenos Aires, Argentina; Research Area, Institute of Oncology 'A.H. Roffo', School of Medicine (FMED), Universidad de Buenos Aires, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Argentina. Electronic address: smranuncolo@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375521%22">Life sciences</searchLink> [Life Sci] 2021 Mar 01; Vol. 268, pp. 118979. <i>Date of Electronic Publication: </i>2021 Jan 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0375521 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0631 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200243205%22">00243205 </searchLink><i>NLM ISO Abbreviation: </i>Life Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33421528 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.lfs.2020.118979 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 118979 Titles: – TitleFull: Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gamboa-Cedeño AM – PersonEntity: Name: NameFull: Díaz M – PersonEntity: Name: NameFull: Cristaldo N – PersonEntity: Name: NameFull: Otero V – PersonEntity: Name: NameFull: Schutz N – PersonEntity: Name: NameFull: Fantl D – PersonEntity: Name: NameFull: Cugliari S – PersonEntity: Name: NameFull: Zerga M – PersonEntity: Name: NameFull: Rojas-Bilbao E – PersonEntity: Name: NameFull: Jauk F – PersonEntity: Name: NameFull: García Rivello H – PersonEntity: Name: NameFull: Nuñez M – PersonEntity: Name: NameFull: Ranuncolo SM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2021 Mar 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1879-0631 Numbering: – Type: volume Value: 268 Titles: – TitleFull: Life sciences Type: main |
| ResultId | 1 |